Privia Health PRVA
- Market cap
- $2.9B
- PE
- 107×
- 3y median 158×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.2×
- EV/EBIT
- 250×
- Revenue, 12 months
- $2.4B
- +24% on a year ago
- Net margin
- 1.2%
- Free cash flow yield
- n/m
- not a meaningful number
Privia Health trades at 107× trailing earnings, cheaper than 75% of the last ten years. Revenue was $2.4B over the last twelve months, up 24% on a year earlier with a 1% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $417.3M+22% | $440.8M+21% | $415.2M+8% | $422.3M+2% | $437.9M+5% | $460.9M+5% | $480.1M+16% | $521.2M+23% | $580.4M+33% | $541.2M+17% | $603.8M+26% | $632.6M+21% | |
| SG&A | $34.5M−8% | $35.8M+8% | $38.2M+22% | $35.8M+9% | $37.7M+10% | $40.9M+14% | $38.6M+1% | $44.3M+24% | $46.6M+24% | $35.7M−13% | $49.6M+28% | $47.7M+8% |
| $5.5M | $1.4M−37% | $823K−88% | $5.1M−27% | $5.8M+5% | $5.2M+270% | $5.2M+534% | $3.3M−35% | $14.4M+148% | $11.3M+115% | $7.4M+42% | $11.8M+253% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $8.4M | $4.3M+26% | $3.8M−55% | $8.1M+3% | $8M−5% | $8M+88% | $8.1M+114% | $5.7M−29% | $16.7M+109% | $13.4M+67% | $9.3M+14% | $16.8M+192% |
| $2.5M | $1.9M | $751K−65% | $3.4M+138% | $4M+61% | $2.7M+37% | $2.1M+180% | $2.5M−28% | $6.9M+72% | $2.8M+5% | $5.6M+166% | $7M+186% | |
| Net income | $5.6M+248% | $2.8M−84% | $3M−59% | $3.5M−52% | $3.5M−37% | $4.4M+55% | $4.2M+41% | $2.7M−23% | $6.9M+94% | $9.2M+108% | $3.1M−27% | $9M+237% |
| $0.05+400% | $0.02−88% | $0.02−67% | $0.03−50% | $0.03−40% | $0.03+50% | $0.03+50% | $0.02−33% | $0.05+67% | $0.07+133% | $0.02−33% | $0.07+250% | |
| 124.9M+0% | 124.8M+9% | 125.1M+1% | 125.3M+1% | 125.8M+1% | 126.1M+1% | 127.8M+2% | 128.4M+3% | 128.8M+2% | 130.4M+3% | 130.9M+2% | 131.8M+3% |
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY20 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest Privia Health's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| PRVAPrivia Health | $2.9B | 107× | 158× | 1.2× | +24% | 1.2% | |
| AVAHAveanna Healthcare | $2.9B | 10.9× | 21.8× | 1.1× | +20% | 10.6% | |
| MDPediatrix Medical | $2.4B | 14.0× | 13.4× | 1.2× | +1% | 9.0% | |
| ADUSAddus HomeCare | $2.3B | 21.4× | 32.4× | 1.5× | +16% | 7.1% | |
| PGNYProgyny | $2.2B | 31.5× | 55.1× | 1.7× | +6% | 6.0% | |
| NHCNational Healthcare | $3.7B | 26.5× | 21.4× | 2.4× | +7% | 9.0% | |
| OPCHOption Care Health | $4.7B | 23.5× | 26.4× | 0.8× | +6% | 3.7% | |
| HCSGHealthcare Services | $1.7B | 14.7× | 26.1× | 0.9× | +4% | 6.6% | |
| ARDTArdent Health | $1.7B | 22.3× | 8.5× | 0.3× | +3% | 1.2% | |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | 3.1× | +20% | 3.2% | |
| CONConcentra Group Holdings Parent | $5B | 25.5× | 17.5× | 2.2× | +14% | 8.7% | |
| Peer median | $2.6B | 22.9× | 24.0× | 1.4× | +6% | 6.9% |
Investors who own it
Investors we follow who held Privia Health at the end of Jun 30, 2026, from their 13F filings.
- Henry EllenbogenDurable Capital Partners2.9% of portfoliotrimmed
More on Privia Health
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #3of 21Hospital and care facility stocks with the fastest earnings growth
- #10of 42Hospital and care facility stocks with the fastest revenue growth
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .